Translation
Notice: This document is an excerpt translation of the original Japanese document and is only for reference purposes. In the event of any
discrepancy between this translated document and the original Japanese document, the latter shall prevail.

Summary of Non-Consolidated Financial Results
for the Six Months Ended September 30, 2021
(Based on Japanese GAAP)
October 29, 2021
Company name:
DAIKEN MEDICAL CO., LTD.
Stock exchange listing: Tokyo
Stock code:
Representative:

7775
President

URL

http://www.daiken-iki.co.jp
Keiichi Yamada

Inquiries:

General Manager Finance and Accounting
Division

Toshikazu Itami

TEL

Scheduled date to file Quarterly Securities Report:
Scheduled date to commence dividend payments:

November 1, 2021
December 1, 2021

Preparation of supplementary material on quarterly financial results:
Holding of quarterly financial results meeting:Yes
No0725-30-3574(Amounts less than one million yen are rounded down)
1. Non-consolidated financial results for the six months ended September 30, 2021 (from April 1, 2021 to September 30, 2021)(1) Non-consolidated operating results (cumulative)
Percentages indicate year-on-year changes
Net sales
Six months ended September 30, 2021
Six months ended September 30, 2020

Millions of yen
4,086
3,771

Operating profit% Millions of yen
8.3565(11.2)
452

Earnings per share

Ordinary profit% Millions of yen
25.0
565(20.0)
488

%
14.2
(15.4)

Diluted earnings per share

Yen
13.93
12.20

Six months ended September 30, 2021
Six months ended September 30, 2020

Profit% Millions of yen
15.7
400(15.7)
350

Yen––(2) Non-consolidated financial position
Total assets

Net assets

Millions of yen
10,796
10,752As of September 30, 2021
As of March 31, 2021

Equity ratio

Millions of yen
6,266
6,182

%
58.0
57.5

2. Cash dividends
Annual dividends per share

Year ended March 31, 2021
Year ending March 31, 2022

1st quarter-end

2nd quarter-end

3rd quarter-end

Fiscal year-end

Yen––

Yen
9.00
9.00

Yen–

Yen
11.00

Yen
20.00

–

11.00

20.00

Year ending March 31, 2022 (Forecast)Total

3. Forecast of non-consolidated financial results for the year ending March 31, 2022 (from April 1, 2021 to March 31, 2022)Percentages indicate year-on-year changes
Net sales
Full year

Millions of yen
8,400

Operating profit% Millions of yen
6.8
1,100

Ordinary profit% Millions of yen
19.4
1,1001Profit% Millions of yen
14.9
770

Earnings per share%
14.0

Yen
26.80

4. Notes(1) Application of special accounting methods for preparing quarterly non-consolidated financial statements: Yes(2) Changes in accounting policies, changes in accounting estimates, and restatement of prior period financial statements
Changes in accounting policies due to revisions to accounting standards and other regulations:
Yes
Changes in accounting policies due to other reasons:
Changes in accounting estimates:

NoNo

Restatement of prior period financial statements:

No(3) Number of issued shares (common shares)
Total number of issued shares at the end of the period (including treasury shares)
As of September 30, 2021

31,840,000 shares As of March 31, 2021

31,840,000 shares

Number of treasury shares at the end of the period
As of September 30, 2021

3,111,559 shares As of March 31, 2021

3,111,559 shares

Average number of shares during the period (cumulative from the beginning of the fiscal year)
Six months ended September 30, 2021

28,728,441 shares Six months ended September 30, 2020

228,728,441 shares

Quarterly non-consolidated financial statements
Non-consolidated balance sheets(Thousands of yen)
As of March 31, 2021

As of September 30, 2021

AssetsCurrent assets
Cash and deposits
Notes and accounts receivable - trade2,170,643
1,597,757

2,368,214
1,283,016

Electronically recorded monetary claims - operating
Finished goods

989,922
891,4121,037,523
1,010,162

Work in process
Raw materials

86,665443,833

73,325
489,018

Other
Allowance for doubtful accounts

92,402(87)

104,867(87)

6,272,550

6,366,040

2,019,367
1,703,670

1,982,250
1,703,670

Total current assets
Non-current assets
Property, plant and equipment
Buildings, net
Land
Other, net

502,053505,998

4,225,091

4,191,920

Intangible assets

21,723

17,878Investments and other assets
Deferred tax assets

166,802

166,80291,404(24,650)

78,782(24,650)

Total property, plant and equipment

Other
Allowance for doubtful accounts
Total investments and other assets
Total non-current assets
Total assets

3233,555

220,933

4,480,370

4,430,731

10,752,921

10,796,771

(Thousands of yen)
As of March 31, 2021

As of September 30, 2021

Liabilities
Current liabilities
Notes and accounts payable - trade849,189

477,373

141,925
1,000,000

535,898
1,500,000

Current portion of long-term borrowings
Income taxes payable

704,034
111,074

622,134
187,150

Accrued expenses
Provision for Sales allowance

179,500
179,346

67,686–

Asset retirement obligations
Other

6,738
175,208–
219,569

Total current liabilities

3,347,018

3,609,812

Non-current liabilities
Long-term borrowings

1,177,859

879,617

Electronically recorded obligations - operating
Short-term borrowings

Other

45,76840,814

1,223,627

920,4314,570,645

4,530,244

Share capital
Capital surplus

495,875
400,875

495,875
400,875

Retained earnings
Treasury shares

7,112,107(1,826,582)

7,196,359(1,826,582)

Total shareholders' equity

6,182,275

6,266,527

6,182,275

6,266,527

10,752,921

10,796,771

Total non-current liabilities
Total liabilities
Net assets
Shareholders' equity

Total net assets
Total liabilities and net assets

4Non-consolidated statements of income (cumulative)(Thousands of yen)Six months ended

Six months ended

September 30, 2020

September 30, 2021

Net sales
Cost of sales

3,771,329
2,090,193

4,086,178
2,268,555

Gross profit

1,681,136

1,817,622

Selling, general and administrative expenses

1,228,702

1,252,281

452,433

565,340

0230

0867

Gain on forfeiture of unclaimed dividends
Subsidy income814
36,072

544–

Miscellaneous income
Other–
1,125

506
213

Total non-operating income

38,242

2,132

1,878

1,962–

146

Operating profit
Non-operating income
Interest income
Compensation income

Non-operating expenses
Interest expenses
Other
Total non-operating expenses
Ordinary profit
Extraordinary losses
Loss on retirement of non-current assets
Total extraordinary losses

1,878

2,109

488,797565,364

165

691

165

691

Profit before income taxes

488,632

564,672

Income taxes

138,006

164,408

Profit350,626

400,2645

Non-consolidated statements of cash flows(Thousands of yen)

Cash flows from operating activities
Profit before income taxes

Six months ended

Six months ended

September 30, 2020

September 30, 2021

488,632

564,672

111,169–

158,755(179,346)

(0)
1,878

(0)
1,962

Decrease (increase) in trade receivables
Decrease (increase) in inventories

267,010(298,233)

267,140(150,594)

Increase (decrease) in trade payables
Loss on retirement of non-current assets(47,890)
165

3,012
691

Subsidy income
Decrease (increase) in accounts receivable - other(36,072)
45,989–
1,435

Increase (decrease) in accounts payable - other
Increase (decrease) in accrued expenses(19,929)(33,547)(10,551)(111,814)

Decrease/increase in consumption taxes receivable/payable
Other, net(85,094)(10,374)

33,626(24,856)

Subtotal

383,701

554,132

Interest and dividends received
Interest paid0(1,898)0(2,022)

Income taxes paid

(163,364)(78,865)

Net cash provided by (used in) operating activities

218,439473,244

Purchase of property, plant and equipment
Purchase of intangible assets(228,663)(3,664)(79,375)(344)

Payments of guarantee deposits
Proceeds from refund of guarantee deposits

(506)
373

(294)
12,845

Payments for asset retirement obligations–(6,479)(232,460)(73,648)

Repayments of long-term borrowings
Dividends paid

(359,134)(316,473)(380,142)(315,855)

Net increase (decrease) in short-term borrowings
Repayments of lease obligations

400,000(4,253)500,000(6,027)

Net cash provided by (used in) financing activities(279,860)(202,024)

Depreciation
Increase (decrease) in provision for sales allowanceInterest and dividend income
Interest expenses

Cash flows from investing activities

Net cash provided by (used in) investing activities
Cash flows from financing activities

Net increase (decrease) in cash and cash equivalents(293,882)

197,571

Cash and cash equivalents at beginning of period

2,365,400

2,170,643

Cash and cash equivalents at end of period

2,071,518

2,368,2146